Cargando…
Can diabetes mellitus modify the plasma concentrations of rifampicin in patients under treatment for tuberculosis?
Rifampicin is a key component of treatment for tuberculosis and its efficacy is determined by the blood levels attained after therapeutic doses. However, there is a high variability of rifampicin blood levels that is related to both the patient and the formulation used. To date, the effect of diabet...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9392073/ https://www.ncbi.nlm.nih.gov/pubmed/32535111 http://dx.doi.org/10.1016/j.bjid.2020.05.007 |